• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Rocket Lab Announces Second Quarter 2024 Financial Results, Posts Record Revenue on 71% Year-on-Year Growth

    8/8/24 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter, ended June 30, 2024.

    Rocket Lab founder and CEO, Sir Peter Beck, said: "This year's second quarter was Rocket Lab's highest revenue quarter in Company history at $106 million. This 71% year-on-year revenue increase demonstrates the strong and growing demand for our launch services and space systems products, and importantly, our team's ability to execute against it. Meanwhile, we reached a critical milestone in the development of our new medium lift rocket Neutron, with the successful completion of the first hot fire for the Archimedes engine. Over the same period, we made significant progress in Neutron production and launch infrastructure with the scaling of engine production facilities, installation of the automated fiber placement machine that will produce Neutron's largest carbon fiber structures, and we furthered development of Launch Complex 3 and the integration and assembly facility on site in Wallops, Virginia. On the small launch front, Electron remains the leading small rocket globally with successful launches in the quarter for government and commercial customers, and demand for it continues to grow with 17 new launches signed so far this year. We also continue to reach development and production milestones across our space systems programs, in which we have more than $720 million in spacecraft under contract. Some significant achievements on this front include the completion of twin Rocket Lab-designed and built satellites for a NASA mission to Mars, as well as completing successful development reviews for the government and commercial constellations we have in work."

    Business Highlights for the Second Quarter 2024, plus updates since June 30, 2024:

    • Achieved our highest revenue quarter in Company history at $106 million.
    • Successful Electron launches for NASA, commercial constellation operators Synspective, Kineis, and the Korea Advanced Institute of Science and Technology (KAIST). Electron remains the most frequently launched small rocket globally and Electron launches have accounted for 64% of all non-SpaceX orbital U.S. launches in 2024 to date.
    • Successfully launched our 50th Electron mission, reaching 50 launches faster than any commercially developed rocket in history.
    • Demonstrated pinpoint deployment accuracy by launching customer payload to within eight meters of target orbit (accepted industry tolerance is typically 15 kilometers).
    • Signed 17 new launch contracts year-to-date, including multi-launch deals with commercial constellation operators, a HASTE (Hypersonic Accelerator Suborbital Test Electron) launch for a government customer, and two highly complex missions for the Department of Defense, including a responsive launch demonstration in which Rocket Lab will build a spacecraft, as well as launch and operate it as an end-to-end space service.
    • Reached major development milestone with successful completion of first Archimedes engine hot fire. Now moving into full production for remaining flight engines.
    • Significant progress made in development and flight hardware of Neutron structures, fairing, avionics, and flight software.
    • Infrastructure development progressing to support first Neutron flight and operational launch cadence, including scaling Archimedes engine production line, arrival of long lead cryogenic systems at launch site, installation of automated fiber placement machine for Neutron production, and entering final construction phase of establishing final assembly facility at Wallops, Virginia.
    • Completed production of two spacecraft for NASA's ESCAPADE mission to Mars, scheduled to launch this year.
    • Signed preliminary terms for $49.4m in state and federal funding, including a portion under the CHIPS Act, to expand production of solar cells in Albuquerque, New Mexico.
    • Progressing development and production of spacecraft for Varda Space Industries, as well as constellations on contract for the Space Development Agency and MDA/Globalstar.
    • Introduced a new satellite dispenser at the Small Satellite Conference in Utah to provide customers with more flexibility when designing spacecraft.

    Third Quarter 2024 Guidance

    For the third quarter of 2024, Rocket Lab expects:

    • Revenue between $100 million and $105 million.
    • Space Systems revenue between $79 million and $84 million.
    • Launch Services revenue of approximately $21 million.
    • GAAP Gross Margins between 25% and 27%.
    • Non-GAAP Gross Margins between 30% and 32%.
    • GAAP Operating Expenses between $80 million and $82 million.
    • Non-GAAP Operating Expenses between $69 million and $71 million.
    • Expected Interest Expense (Income), net $1 million.
    • Adjusted EBITDA loss of $31 million to $33 million.
    • Basic Shares Outstanding of 498 million.

    See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q3 2024 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $12 million to $14 million in Q3 2024.

    Conference Call Information

    Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our second quarter, to provide our outlook for the third quarter, and other updates.

    The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events

    About Rocket Lab

    Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, various satellite platforms, and is developing the Neutron launch vehicle for large spacecraft and constellation deployment. From its first orbital launch in January 2018 to date, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 191 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch site in Virginia, USA. To learn more, visit www.rocketlabusa.com.

    + FORWARD-LOOKING STATEMENTS

    This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release, including statements regarding our expectations of financial results for the third quarter of 2024, strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. Words such as, but not limited to, "anticipate," "aim," "believe," "contemplate," "continue," "could," "design," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "suggest," "strategy," "target," "will," "would," and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on Rocket Lab's current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab's control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including risks related to delays and disruptions in expansion efforts; delays in the development of our Neutron rocket; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased competition in our industry due in part to rapid technological development; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; general economic uncertainty and turbulence which could impact our customers' ability to pay what we are owed; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design, in engineering, in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; launch failures; natural disasters and epidemics or pandemics; any inability to effectively integrate recently acquired assets; a US government shutdown or delays in government funding; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab's filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in Rocket Lab's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 28, 2024, and elsewhere. There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

    Notes to Editor: All dollar amounts in this press release are expressed in U.S. dollars, unless otherwise stated.

    + USE OF NON-GAAP FINANCIAL MEASURES

    We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

    + ADJUSTED EBITDA

    EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

    + OTHER NON-GAAP FINANCIAL MEASURES

    Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    Revenues

     

    $

    106,251

     

     

    $

    62,045

     

     

    $

    199,018

     

     

    $

    116,940

     

    Cost of revenues

     

     

    79,089

     

     

     

    47,452

     

     

     

    147,682

     

     

     

    95,990

     

    Gross profit

     

     

    27,162

     

     

     

    14,593

     

     

     

    51,336

     

     

     

    20,950

     

    Operating expenses:

     

     

     

     

     

     

     

     

    Research and development, net

     

     

    39,912

     

     

     

    31,035

     

     

     

    78,416

     

     

     

    54,940

     

    Selling, general and administrative

     

     

    30,524

     

     

     

    28,717

     

     

     

    59,273

     

     

     

    57,186

     

    Total operating expenses

     

     

    70,436

     

     

     

    59,752

     

     

     

    137,689

     

     

     

    112,126

     

    Operating loss

     

     

    (43,274

    )

     

     

    (45,159

    )

     

     

    (86,353

    )

     

     

    (91,176

    )

    Other income (expense):

     

     

     

     

     

     

     

     

    Interest expense, net

     

     

    (824

    )

     

     

    (745

    )

     

     

    (1,722

    )

     

     

    (1,430

    )

    (Loss) gain on foreign exchange

     

     

    (286

    )

     

     

    (90

    )

     

     

    25

     

     

     

    44

     

    Other income, net

     

     

    1,893

     

     

     

    866

     

     

     

    1,304

     

     

     

    2,343

     

    Total other income (expense), net

     

     

    783

     

     

     

    31

     

     

     

    (393

    )

     

     

    957

     

    Loss before income taxes

     

     

    (42,491

    )

     

     

    (45,128

    )

     

     

    (86,746

    )

     

     

    (90,219

    )

    Benefit (provision) for income taxes

     

     

    860

     

     

     

    (761

    )

     

     

    855

     

     

     

    (1,287

    )

    Net loss

     

    $

    (41,631

    )

     

    $

    (45,889

    )

     

    $

    (85,891

    )

     

    $

    (91,506

    )

    Net loss per share attributable to Rocket Lab USA, Inc.:

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.08

    )

     

    $

    (0.10

    )

     

    $

    (0.17

    )

     

    $

    (0.19

    )

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    494,190,708

     

     

     

    479,735,858

     

     

     

    492,092,709

     

     

     

    477,977,551

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    AS OF JUNE 30, 2024 AND DECEMBER 31, 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

     

     

     

     

    June 30, 2024

    (unaudited)

     

    December 31,

    2023

    Assets

     

     

     

     

    Current assets:

     

     

     

     

    Cash and cash equivalents

     

    $

    340,911

     

     

    $

    162,518

     

    Marketable securities, current

     

     

    155,844

     

     

     

    82,255

     

    Accounts receivable, net

     

     

    50,476

     

     

     

    35,176

     

    Contract assets

     

     

    18,744

     

     

     

    12,951

     

    Inventories

     

     

    104,539

     

     

     

    107,857

     

    Prepaids and other current assets

     

     

    81,322

     

     

     

    66,949

     

    Assets held for sale

     

     

    —

     

     

     

    9,016

     

    Total current assets

     

     

    751,836

     

     

     

    476,722

     

    Non-current assets:

     

     

     

     

    Property, plant and equipment, net

     

     

    155,894

     

     

     

    145,409

     

    Intangible assets, net

     

     

    64,243

     

     

     

    68,094

     

    Goodwill

     

     

    71,020

     

     

     

    71,020

     

    Right-of-use assets - operating leases

     

     

    55,283

     

     

     

    59,401

     

    Right-of-use assets - finance leases

     

     

    14,667

     

     

     

    14,987

     

    Marketable securities, non-current

     

     

    46,411

     

     

     

    79,247

     

    Restricted cash

     

     

    3,640

     

     

     

    3,916

     

    Deferred income tax assets, net

     

     

    1,573

     

     

     

    3,501

     

    Other non-current assets

     

     

    24,031

     

     

     

    18,914

     

    Total assets

     

    $

    1,188,598

     

     

    $

    941,211

     

    Liabilities and Stockholders' Equity

     

     

     

     

    Current liabilities:

     

     

     

     

    Trade payables

     

    $

    26,468

     

     

    $

    29,303

     

    Accrued expenses

     

     

    11,937

     

     

     

    5,590

     

    Employee benefits payable

     

     

    13,918

     

     

     

    16,342

     

    Contract liabilities

     

     

    184,042

     

     

     

    139,338

     

    Current installments of long-term borrowings

     

     

    11,345

     

     

     

    17,764

     

    Other current liabilities

     

     

    18,731

     

     

     

    15,036

     

    Total current liabilities

     

     

    266,441

     

     

     

    223,373

     

    Non-current liabilities:

     

     

     

     

    Convertible senior notes, net

     

     

    344,344

     

     

     

    —

     

    Long-term borrowings, net, excluding current installments

     

     

    50,061

     

     

     

    87,587

     

    Non-current operating lease liabilities

     

     

    52,888

     

     

     

    56,099

     

    Non-current finance lease liabilities

     

     

    15,112

     

     

     

    15,238

     

    Deferred tax liabilities

     

     

    619

     

     

     

    426

     

    Other non-current liabilities

     

     

    3,953

     

     

     

    3,944

     

    Total liabilities

     

     

    733,418

     

     

     

    386,667

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

    Stockholders' equity:

     

     

     

     

    Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued and outstanding shares: 496,500,849 and 488,923,055 at June 30, 2024 and December 31, 2023, respectively

     

     

    50

     

     

     

    49

     

    Additional paid-in capital

     

     

    1,165,322

     

     

     

    1,176,484

     

    Accumulated deficit

     

     

    (709,417

    )

     

     

    (623,526

    )

    Accumulated other comprehensive income (loss)

     

     

    (775

    )

     

     

    1,537

     

    Total stockholders' equity

     

     

    455,180

     

     

     

    554,544

     

    Total liabilities and stockholders' equity

     

    $

    1,188,598

     

     

    $

    941,211

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023

    (unaudited; in thousands)

     

     

     

    For the Six Months Ended June 30,

     

     

    2024

     

    2023

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net loss

     

    $

    (85,891

    )

     

    $

    (91,506

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

    Depreciation and amortization

     

     

    16,421

     

     

     

    13,785

     

    Stock-based compensation expense

     

     

    27,048

     

     

     

    29,300

     

    (Gain) loss on disposal of assets

     

     

    (1,192

    )

     

     

    27

     

    Loss on extinguishment of long-term debt

     

     

    1,330

     

     

     

    —

     

    Amortization of debt issuance costs and discount

     

     

    1,454

     

     

     

    1,431

     

    Noncash lease expense

     

     

    2,959

     

     

     

    2,026

     

    Change in the fair value of contingent consideration

     

     

    (218

    )

     

     

    1,600

     

    Accretion of marketable securities purchased at a discount

     

     

    (1,605

    )

     

     

    (2,116

    )

    Deferred income taxes

     

     

    2,000

     

     

     

    248

     

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    (15,420

    )

     

     

    11,433

     

    Contract assets

     

     

    (5,793

    )

     

     

    (7,264

    )

    Inventories

     

     

    2,530

     

     

     

    (10,611

    )

    Prepaids and other current assets

     

     

    (4,638

    )

     

     

    (10,839

    )

    Other non-current assets

     

     

    (5,289

    )

     

     

    (5,634

    )

    Trade payables

     

     

    (1,930

    )

     

     

    13,234

     

    Accrued expenses

     

     

    6,566

     

     

     

    (2,845

    )

    Employee benefits payables

     

     

    (1,064

    )

     

     

    4,116

     

    Contract liabilities

     

     

    44,718

     

     

     

    26,230

     

    Other current liabilities

     

     

    4,222

     

     

     

    (1,881

    )

    Non-current lease liabilities

     

     

    (2,860

    )

     

     

    (1,942

    )

    Other non-current liabilities

     

     

    1,064

     

     

     

    (241

    )

    Net cash used in operating activities

     

     

    (15,588

    )

     

     

    (31,449

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

    Purchases of property, equipment and software

     

     

    (34,521

    )

     

     

    (23,246

    )

    Proceeds on disposal of assets, net

     

     

    10,815

     

     

     

    —

     

    Cash paid for asset acquisition

     

     

    —

     

     

     

    (16,119

    )

    Purchases of marketable securities

     

     

    (113,274

    )

     

     

    (132,000

    )

    Maturities of marketable securities

     

     

    73,883

     

     

     

    154,176

     

    Net cash used in investing activities

     

     

    (63,097

    )

     

     

    (17,189

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

    Proceeds from the exercise of stock options and public warrants

     

     

    1,159

     

     

     

    1,808

     

    Proceeds from Employee Stock Purchase Plan

     

     

    2,665

     

     

     

    2,522

     

    Proceeds from sale of employees restricted stock units to cover taxes

     

     

    9,270

     

     

     

    7,801

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

     

    (9,479

    )

     

     

    (6,968

    )

    Payment of contingent consideration

     

     

    —

     

     

     

    (1,000

    )

    Purchase of capped calls related to issuance of convertible senior notes

     

     

    (43,168

    )

     

     

    —

     

    Proceeds from issuance of convertible senior notes

     

     

    355,000

     

     

     

    —

     

    Repayments on Trinity Loan Agreement

     

     

    (45,822

    )

     

     

    —

     

    Payment of debt issuance costs

     

     

    (12,205

    )

     

     

    —

     

    Finance lease principal payments

     

     

    (477

    )

     

     

    (160

    )

    Net cash provided by financing activities

     

     

    256,943

     

     

     

    4,003

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    (141

    )

     

     

    (482

    )

    Net increase (decrease) in cash and cash equivalents and restricted cash

     

     

    178,117

     

     

     

    (45,117

    )

    Cash and cash equivalents, and restricted cash, beginning of period

     

     

    166,434

     

     

     

    245,871

     

    Cash and cash equivalents, and restricted cash, end of period

     

    $

    344,551

     

     

    $

    200,754

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023

    (unaudited; in thousands)

     

    The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    NET LOSS

     

    $

    (41,631

    )

     

    $

    (45,889

    )

     

    $

    (85,891

    )

     

    $

    (91,506

    )

    Depreciation

     

     

    4,796

     

     

     

    3,513

     

     

     

    9,720

     

     

     

    7,226

     

    Amortization

     

     

    3,312

     

     

     

    3,239

     

     

     

    6,701

     

     

     

    6,559

     

    Stock-based compensation expense

     

     

    13,955

     

     

     

    15,264

     

     

     

    27,048

     

     

     

    29,300

     

    Transaction costs

     

     

    12

     

     

     

    4

     

     

     

    384

     

     

     

    169

     

    Interest expense, net

     

     

    824

     

     

     

    745

     

     

     

    1,722

     

     

     

    1,430

     

    Change in fair value of contingent consideration

     

     

    53

     

     

     

    1,300

     

     

     

    (218

    )

     

     

    1,600

     

    Performance reserve escrow

     

     

    —

     

     

     

    1,788

     

     

     

    —

     

     

     

    3,626

     

    (Benefit) provision for income taxes

     

     

    (860

    )

     

     

    761

     

     

     

    (855

    )

     

     

    1,287

     

    Loss (gain) on foreign exchange

     

     

    286

     

     

     

    90

     

     

     

    (25

    )

     

     

    (44

    )

    Accretion of marketable securities purchased at a discount

     

     

    (764

    )

     

     

    (989

    )

     

     

    (1,606

    )

     

     

    (2,154

    )

    (Gain) loss on disposal of assets

     

     

    (1,195

    )

     

     

    22

     

     

     

    (1,192

    )

     

     

    27

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (3,841

    )

    Loss on extinguishment of debt

     

     

    —

     

     

     

    —

     

     

     

    1,330

     

     

     

    —

     

    ADJUSTED EBITDA

     

    $

    (21,212

    )

     

    $

    (20,152

    )

     

    $

    (42,882

    )

     

    $

    (46,321

    )

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

    GAAP Gross profit

     

    $

    27,162

     

     

    $

    14,593

     

     

    $

    51,336

     

     

    $

    20,950

     

    Stock-based compensation

     

     

    3,673

     

     

     

    3,330

     

     

     

    7,176

     

     

     

    7,143

     

    Amortization of purchased intangibles and favorable lease

     

     

    1,741

     

     

     

    1,709

     

     

     

    3,484

     

     

     

    3,419

     

    Performance reserve escrow

     

     

    —

     

     

     

    76

     

     

     

    —

     

     

     

    133

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (2,130

    )

    Non-GAAP Gross profit

     

    $

    32,576

     

     

    $

    19,708

     

     

    $

    61,996

     

     

    $

    29,515

     

    Non-GAAP Gross margin

     

     

    30.7

    %

     

     

    31.8

    %

     

     

    31.2

    %

     

     

    25.2

    %

     

     

     

     

     

     

     

     

     

    GAAP Research and development, net

     

    $

    39,912

     

     

    $

    31,035

     

     

    $

    78,416

     

     

    $

    54,940

     

    Stock-based compensation

     

     

    (5,049

    )

     

     

    (6,652

    )

     

     

    (9,034

    )

     

     

    (11,674

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (155

    )

     

     

    (9

    )

     

     

    (384

    )

     

     

    (18

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    631

     

    Non-GAAP Research and development, net

     

    $

    34,708

     

     

    $

    24,374

     

     

    $

    68,998

     

     

    $

    43,879

     

     

     

     

     

     

     

     

     

     

    GAAP Selling, general and administrative

     

    $

    30,524

     

     

    $

    28,717

     

     

    $

    59,273

     

     

    $

    57,186

     

    Stock-based compensation

     

     

    (5,233

    )

     

     

    (5,282

    )

     

     

    (10,838

    )

     

     

    (10,483

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (1,382

    )

     

     

    (1,395

    )

     

     

    (2,314

    )

     

     

    (2,829

    )

    Transaction costs

     

     

    (12

    )

     

     

    (4

    )

     

     

    (384

    )

     

     

    (169

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,712

    )

     

     

    —

     

     

     

    (3,493

    )

    Change in fair value of contingent consideration

     

     

    (53

    )

     

     

    (1,300

    )

     

     

    218

     

     

     

    (1,600

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,080

     

    Non-GAAP Selling, general and administrative

     

    $

    23,844

     

     

    $

    19,024

     

     

    $

    45,955

     

     

    $

    39,692

     

     

     

     

     

     

     

     

     

     

    GAAP Operating expenses

     

    $

    70,436

     

     

    $

    59,752

     

     

    $

    137,689

     

     

    $

    112,126

     

    Stock-based compensation

     

     

    (10,282

    )

     

     

    (11,934

    )

     

     

    (19,872

    )

     

     

    (22,157

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (1,537

    )

     

     

    (1,404

    )

     

     

    (2,698

    )

     

     

    (2,847

    )

    Transaction costs

     

     

    (12

    )

     

     

    (4

    )

     

     

    (384

    )

     

     

    (169

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,712

    )

     

     

    —

     

     

     

    (3,493

    )

    Change in fair value of contingent consideration

     

     

    (53

    )

     

     

    (1,300

    )

     

     

    218

     

     

     

    (1,600

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,711

     

    Non-GAAP Operating expenses

     

    $

    58,552

     

     

    $

    43,398

     

     

    $

    114,953

     

     

    $

    83,571

     

     

     

     

     

     

     

     

     

     

    GAAP Operating loss

     

    $

    (43,274

    )

     

    $

    (45,159

    )

     

    $

    (86,353

    )

     

    $

    (91,176

    )

    Total non-GAAP adjustments

     

     

    17,298

     

     

     

    21,469

     

     

     

    33,396

     

     

     

    37,120

     

    Non-GAAP Operating loss

     

    $

    (25,976

    )

     

    $

    (23,690

    )

     

    $

    (52,957

    )

     

    $

    (54,056

    )

     

     

     

     

     

     

     

     

     

    GAAP Total other income (expense), net

     

    $

    783

     

     

    $

    31

     

     

    $

    (393

    )

     

    $

    957

     

    Loss (gain) on foreign exchange

     

     

    286

     

     

     

    90

     

     

     

    (25

    )

     

     

    (44

    )

    (Gain) loss on disposal of assets

     

     

    (1,195

    )

     

     

    22

     

     

     

    (1,192

    )

     

     

    27

     

    Loss on extinguishment of debt

     

     

    —

     

     

     

    —

     

     

     

    1,330

     

     

     

    —

     

    Non-GAAP Total other income (expense), net

     

    $

    (126

    )

     

    $

    143

     

     

    $

    (280

    )

     

    $

    940

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240808283474/en/

    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    SEC Filings

    See more
    • SEC Form 144 filed by Rocket Lab USA Inc.

      144 - Rocket Lab Corp (0001819994) (Subject)

      5/30/25 7:41:36 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 144 filed by Rocket Lab USA Inc.

      144 - Rocket Lab Corp (0001819994) (Subject)

      5/30/25 7:39:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 424B5 filed by Rocket Lab USA Inc.

      424B5 - Rocket Lab Corp (0001819994) (Filer)

      5/30/25 8:03:35 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ATL Partners Announces Sale of Geost to Rocket Lab and Launches New Defense Electronics Platform, Trident Solutions

      ATL Partners ("ATL"), a sector-focused private equity firm, today announced the sale of Geost, LLC ("Geost"), a subsidiary of its portfolio company LightRidge Solutions, to Rocket Lab USA, Inc. (NASDAQ:RKLB), a leading space systems and launch services provider. This transaction represents a successful exit for ATL, which acquired Geost in 2021 and, in partnership with management, scaled the business into a market leader in electro-optical and infrared (EO/IR) sensing technologies supporting high-priority national security space missions. With more than 20 years of flight heritage across classified and unclassified missions, Geost delivers advanced EO/IR sensor systems for missile warning

      5/27/25 4:20:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Enters Payload Market with Agreement to Acquire Geost, Positioning Itself as Disruptive Prime to U.S. National Security

      The strategic acquisition would create an entirely new category for Rocket Lab, positioning the Company as a disruptor for national security space. Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced the signing of a definitive agreement to acquire the parent holding company of Geost, LLC ("Geost"), a Tucson, Arizona-based electro-optical and infrared (EO/IR) payload development and manufacturing company and provider to high-priority national security satellites, from Lightridge Solutions, a portfolio company of ATL Partners, for $275 million in a mix of $125 million of cash and $150 million in private

      5/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • BlackSky and Rocket Lab Establish Launch Window for Second Gen-3 Satellite

      "Full Stream Ahead" mission to add very high-resolution 35-centimeter imaging capability to BlackSky's high-cadence, low-latency data and AI-enabled analytics offerings BlackSky Technology Inc. (NYSE: BKSY) and Rocket Lab USA, Inc. (NASDAQ:RKLB) have established a launch window opening May 27 for the second Gen-3 satellite. The launch, named "Full Stream Ahead," will add very high-resolution 35-centimeter imaging capability to BlackSky's high-cadence, low-latency data and AI-enabled analytics offerings. "Each successive Gen-3 launch represents a major step forward for our global defense and intelligence customer base with the prospect of new mission applications that will be enabled by co

      5/22/25 8:30:00 AM ET
      $BKSY
      $RKLB
      Radio And Television Broadcasting And Communications Equipment
      Technology
      Military/Government/Technical
      Industrials

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • JMP Securities initiated coverage on Rocket Lab USA

      JMP Securities initiated coverage of Rocket Lab USA with a rating of Mkt Perform

      9/12/24 9:09:33 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Rocket Lab USA from Overweight to Equal-Weight and set a new price target of $6.00 from $8.00 previously

      7/15/24 7:47:38 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Kampani Arjun sold $158,152 worth of shares (5,277 units at $29.97), decreasing direct ownership by 0.92% to 569,606 units (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      5/30/25 6:06:28 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $76,999 worth of shares (2,569 units at $29.97), decreasing direct ownership by 0.18% to 1,415,075 units (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      5/30/25 6:01:49 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $846,607 worth of shares (46,388 units at $18.25), decreasing direct ownership by 3% to 1,417,644 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:41:08 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Leadership Updates

    Live Leadership Updates

    See more
    • Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

      4/23/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Appoints Chief Operations Officer to Support Company Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the appointment of Frank Klein as its new Chief Operations Officer (COO), effective September 16th, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910807125/en/Rocket Lab's new Chief Operations Officer, Frank Klein. (Photo: Business Wire) Frank Klein joins Rocket Lab with more than 30 years of international manufacturing experience and leadership in the automotive industry. At Rocket Lab, Mr. Klein will lead the Company's efforts to scale manufacturing of spacecraft, launch vehicles, a

      9/10/24 7:00:00 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Former Lockheed Martin Chief Financial Officer Joins Rocket Lab Board of Directors

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that Kenneth (Ken) Possenriede has been appointed to the Company's Board of Directors. A seasoned executive with strong business and financial acumen, Mr. Possenriede joins Rocket Lab after a 35-year career at Lockheed Martin Corporation in financial leadership positions, including serving as Chief Financial Officer (CFO). "Ken's deep aerospace and defense industry experience, combined with accomplished financial leadership, adds even more horsepower to Rocket Lab's already impressive board line-up," said Rocket Lab's founder and Chief Executive Offic

      8/22/24 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/5/24 9:49:25 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/3/24 9:39:57 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

      SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      11/12/24 4:45:55 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Financials

    Live finance-specific insights

    See more
    • Rocket Lab Enters Payload Market with Agreement to Acquire Geost, Positioning Itself as Disruptive Prime to U.S. National Security

      The strategic acquisition would create an entirely new category for Rocket Lab, positioning the Company as a disruptor for national security space. Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced the signing of a definitive agreement to acquire the parent holding company of Geost, LLC ("Geost"), a Tucson, Arizona-based electro-optical and infrared (EO/IR) payload development and manufacturing company and provider to high-priority national security satellites, from Lightridge Solutions, a portfolio company of ATL Partners, for $275 million in a mix of $125 million of cash and $150 million in private

      5/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Date of First Quarter 2025 Financial Results

      Rocket Lab USA, Inc. ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the first quarter 2025 following the close of the U.S. markets on Thursday, May 8, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.rocketlabusa.com/investors. About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufactu

      4/3/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials